Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Leqvioleqvio.com · Low evidenceLEQVIO (inclisiran) is a prescription cholesterol-lowering injection that reduces bad LDL cholesterol by approximately 50% in adults with atherosclerotic cardiovascular disease. After two initial doses, patients receive it only twice a year, on top of maximally tolerated statin therapy.
Parse Score